Part I [Business](index=6&type=section&id=Item%201.%20Business) Amprius develops and manufactures ultra-high energy density lithium-ion batteries for aviation and EV markets, scaling to GWh-scale [Overview and Corporate Background](index=6&type=section&id=Overview%20and%20Corporate%20Background) - Amprius develops and commercially produces ultra-high energy density lithium-ion batteries featuring a disruptive silicon anode technology, which offers superior performance over conventional graphite batteries[17](index=17&type=chunk) - The company's primary markets are aviation applications like Unmanned Aerial Systems (UAS) and High-Altitude Pseudo Satellites (HAPS), with over **100** customers including AALTO Airbus, AeroVironment, and the U.S. Army[18](index=18&type=chunk) - Amprius offers two product platforms: **SiMaxx** (silicon nanowire) and **SiCore** (developed with Berzelius). The company is expanding its Fremont facility's capacity tenfold to **2 MWh** and building a new **GWh-scale facility** in Brighton, Colorado[19](index=19&type=chunk) - As of December 31, 2023, the company held **$45.8 million in cash** and expects to fund operations for at least the next twelve months through cash on hand, cash flows, and proceeds from its At Market Issuance Sales Agreement[23](index=23&type=chunk) [Industry Background and Market Opportunity](index=7&type=section&id=Industry%20Background%20and%20Market%20Opportunity) Electrification drives demand for advanced batteries in aviation and EVs, creating significant market opportunities - The shift to electrification in transportation is driven by a focus on sustainable energy, creating demand for advanced battery technologies in aviation (UAS, eVTOL) and ground vehicles (EVs)[24](index=24&type=chunk) Total Addressable Market (TAM) Forecasts | Market Segment | TAM by 2030/2033 | Source Year | | :--- | :--- | :--- | | Unmanned Aerial Systems (UAS) Batteries | ~$27.0 billion | 2030 | | Electric Air Mobility Batteries | ~$6.0 billion | 2030 | | Global EV Battery Market | $509.0 billion | 2033 | [Our Solution and Competitive Strengths](index=8&type=section&id=Our%20Solution%20and%20Competitive%20Strengths) Amprius's silicon anode technology provides superior battery performance with high energy density and fast charging, protected by robust IP - Amprius replaces traditional graphite anodes with a highly engineered silicon material that has a lithium storage capacity nearly **10 times greater** than graphite, significantly enhancing battery performance[34](index=34&type=chunk) Performance Metrics vs. Graphite Anode Batteries | Performance Metric | Graphite Anode Cells | Amprius SiMaxx Cells | | :--- | :--- | :--- | | Specific Energy (Wh/kg) | ~215-285 | 320-500 | | Energy Density (Wh/L) | ~530-715 | 805-1,300 | | Charging Time to 80% | 30 minutes | <6 minutes | | Cycle Life | 500-1,000 cycles | 200-1,200 cycles | - In March 2023, prototype **SiMaxx** cells were verified to deliver energy density greater than **504 Wh/kg** and **1,321 Wh/L**. In August 2023, the company unveiled a new cell with **400 Wh/kg** energy density and **10C** continuous discharge capability[38](index=38&type=chunk) - The company's technology is protected by a robust intellectual property portfolio, including over **80 issued patents** and pending applications, developed over more than **10 years**[42](index=42&type=chunk) [Our Products and Customers](index=10&type=section&id=Our%20Products%20and%20Customers) Amprius offers SiMaxx and SiCore battery platforms for aviation, with an EV-capable cell under development for future markets - The **SiMaxx** product platform includes High Energy cells (up to **500 Wh/kg**) for applications like HAPS, High Power cells (**400 Wh/kg**, **10C** discharge) for eVTOLs, and Balanced Energy/Power cells for UAS[44](index=44&type=chunk)[46](index=46&type=chunk)[48](index=48&type=chunk) - The **SiCore** product platform, developed with Berzelius, offers high energy density (up to **400 Wh/kg**) and long cycle life (up to **1,200 cycles**). It is available in various form factors and serves as a capacity bridge while **SiMaxx** production scales[49](index=49&type=chunk) - Amprius is developing an **EV-capable cell** and was awarded a contract from the U.S. Advanced Battery Consortium (USABC) to develop a low-cost, fast-charge battery meeting **2025 EV targets**, including >**400 Wh/kg** specific energy and **1,000 cycles**[53](index=53&type=chunk) [Manufacturing, Supply, and Growth Strategy](index=12&type=section&id=Manufacturing%2C%20Supply%2C%20and%20Growth%20Strategy) Amprius is scaling SiMaxx anode fabrication and building a GWh-scale facility in Colorado to meet demand and expand markets - **SiMaxx** anodes are fabricated using a proprietary Chemical Vapor Deposition (CVD) process. The company is working with centrotherm to develop high-volume anode fabrication tools[58](index=58&type=chunk)[59](index=59&type=chunk) - The company is building a **GWh-scale manufacturing facility** in a **774,000 sq. ft.** leased space in Brighton, Colorado. The initial phase is expected to have up to **500 MWh** capacity[65](index=65&type=chunk)[66](index=66&type=chunk) - Key growth strategies include completing the large-scale manufacturing facility, leveraging toll manufacturing for **SiCore** batteries, reducing costs through scale, extending its first-mover advantage in aviation, and expanding into new markets like EVs[66](index=66&type=chunk)[67](index=67&type=chunk)[68](index=68&type=chunk) - Capital equipment expenditures for the initial **500 MWh** capacity in Colorado are estimated to be between **$75.0 million and $100.0 million**, excluding facility construction and build-out costs[68](index=68&type=chunk) [Competition and Human Capital](index=15&type=section&id=Competition%20and%20Human%20Capital) Amprius competes with traditional and silicon composite anode manufacturers, supported by a dedicated team of 88 personnel - Competitors include traditional graphite anode manufacturers (CATL, Panasonic, Samsung SDI) and companies developing silicon composite anodes (Enevate, Enovix, Sila Nanotechnologies)[77](index=77&type=chunk)[78](index=78&type=chunk) - As of December 31, 2023, Amprius had **88 personnel** (**80 full-time employees**, **4 temporary employees**, and **4 contractors**), with **45 full-time employees** in manufacturing and **19** in R&D[86](index=86&type=chunk)[87](index=87&type=chunk) [Risk Factors](index=17&type=section&id=Item%201A.%20Risk%20Factors) The company faces significant risks in technology, manufacturing, market, capital, IP, regulatory compliance, and internal controls - **Technology & Manufacturing Risks:** The company may not succeed in developing high-volume manufacturing lines that meet quality and cost targets, and its reliance on third parties for **SiCore** batteries and complex equipment for **SiMaxx** production introduces significant operational risks[90](index=90&type=chunk)[91](index=91&type=chunk)[96](index=96&type=chunk) - **Business & Financial Risks:** The company is an early-stage company with a history of losses and will require additional capital for growth. The battery market is intensely competitive, and future sales depend on the growth of new markets like electric aviation, which may develop slower than expected[91](index=91&type=chunk)[92](index=92&type=chunk) - **Regulatory & IP Risks:** The business relies heavily on its intellectual property portfolio and is subject to complex regulations, including environmental laws, export controls, and anti-corruption laws. Failure to comply could result in significant penalties[92](index=92&type=chunk) - **Internal Control Risks:** The company has previously identified and has not yet fully remediated material weaknesses in its internal control over financial reporting, which could affect its ability to report financial results accurately and on time[92](index=92&type=chunk)[170](index=170&type=chunk)[171](index=171&type=chunk) [Unresolved Staff Comments](index=46&type=section&id=Item%201B.%20Unresolved%20Staff%20Comments) The company reports no unresolved staff comments from the SEC - None[273](index=273&type=chunk) [Cybersecurity](index=46&type=section&id=Item%201C.%20Cybersecurity) Amprius manages cybersecurity with board oversight, periodic risk assessments, and employee training, having experienced past threats - The Board of Directors, led by the Audit Committee, oversees enterprise risk management, including cybersecurity threats. Management provides quarterly cybersecurity reports to the board[277](index=277&type=chunk) - The President of Amprius Lab and the Chief Technology Officer are responsible for developing and implementing the information security program. The company engages third-party vendors for simulations and requires all employees to complete regular cybersecurity training[278](index=278&type=chunk) - The company has experienced past threats, including a ransomware incident in **December 2021**, but states that such risks have not materially affected the company to date[190](index=190&type=chunk)[279](index=279&type=chunk) [Properties](index=47&type=section&id=Item%202.%20Properties) Amprius leases facilities in Fremont, CA for HQ and manufacturing, and in Brighton, CO for its future GWh-scale production Leased Properties as of December 31, 2023 | Location | Size (sq. ft.) | Use | Lease Expiration | | :--- | :--- | :--- | :--- | | Fremont, CA | ~51,000 | HQ, R&D, Manufacturing | June 2027 | | Brighton, CO | ~774,000 | Future GWh-scale Facility | May 2039 | [Legal Proceedings](index=47&type=section&id=Item%203.%20Legal%20Proceedings) The company is not currently a party to any litigation expected to materially affect its business - Amprius is not currently a party to any legal proceedings that are likely to have a material adverse effect on the business[281](index=281&type=chunk) [Mine Safety Disclosures](index=48&type=section&id=Item%204.%20Mine%20Safety%20Disclosures) This item is not applicable to the company - None[282](index=282&type=chunk) Part II [Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities](index=49&type=section&id=Item%205.%20Market%20for%20Registrant%27s%20Common%20Equity%2C%20Related%20Stockholder%20Matters%20and%20Issuer%20Purchases%20of%20Equity%20Securities) Common stock and warrants trade on NYSE; no dividends are anticipated as earnings are retained for operations - Common stock and public warrants are listed on the NYSE under symbols "AMPX" and "AMPX.W" since **September 15, 2022**[285](index=285&type=chunk) - The company has never declared or paid dividends and does not intend to do so in the foreseeable future, retaining all funds for business operations[287](index=287&type=chunk) [Management's Discussion and Analysis of Financial Condition and Results of Operations](index=49&type=section&id=Item%207.%20Management%27s%20Discussion%20and%20Analysis%20of%20Financial%20Condition%20and%20Results%20of%20Operations) Revenue increased **105%** to **$9.1 million**, but net loss widened to **$36.8 million** due to higher costs, with **$45.8 million** cash on hand [Results of Operations](index=55&type=section&id=Results%20of%20Operations) Results of Operations (in thousands) | | Year ended Dec 31, 2023 | Year ended Dec 31, 2022 | Change ($) | Change (%) | | :--- | :--- | :--- | :--- | :--- | | Revenue | $9,053 | $4,409 | $4,644 | 105% | | Cost of revenue | $23,729 | $10,063 | $13,666 | 136% | | Gross loss | $(14,676) | $(5,654) | $(9,022) | 160% | | R&D | $3,677 | $2,027 | $1,650 | 81% | | SG&A | $20,356 | $10,360 | $9,996 | 96% | | Net loss | $(36,776) | $(17,332) | $(19,444) | 112% | - Revenue increased by **$4.6 million (105%)** in 2023, driven by a **$2.6 million** increase in battery sales and a **$2.0 million** increase in non-recurring development service revenue[324](index=324&type=chunk) - Cost of revenues rose by **$13.7 million (136%)**, primarily due to a **$10.3 million** increase in production costs, including nonrecurring fees for the planned **GWh-scale facility** in Brighton, Colorado[325](index=325&type=chunk) - Selling, general and administrative expenses grew by **$10.0 million (96%)**, mainly due to increased professional fees (**$5.2M**), personnel costs (**$3.0M**), and corporate insurance (**$1.2M**) following the transition to a public company[329](index=329&type=chunk) [Liquidity and Capital Resources](index=56&type=section&id=Liquidity%20and%20Capital%20Resources) - As of December 31, 2023, the company had **$45.8 million in cash and cash equivalents**. Management believes this, along with operating cash flows and proceeds from the At Market Financing, is sufficient to fund operations for at least the next twelve months[332](index=332&type=chunk) - The company has an At Market Issuance Sales Agreement to sell up to **$100.0 million** of common stock. As of March 18, 2024, aggregate proceeds were approximately **$6.9 million**[333](index=333&type=chunk) - Capital expenditures for the initial **500 MWh** phase of the Brighton, Colorado facility are estimated to be between **$75.0 million and $100.0 million**, excluding construction and build-out costs[337](index=337&type=chunk) - In June 2023, the company and the U.S. Department of Energy mutually agreed to discontinue negotiations for a **$50.0 million** cost-sharing grant[335](index=335&type=chunk) Summary of Cash Flows (in thousands) | | Year ended Dec 31, 2023 | Year ended Dec 31, 2022 | | :--- | :--- | :--- | | Net cash used in operating activities | $(25,553) | $(13,882) | | Net cash used in investing activities | $(17,550) | $(1,481) | | Net cash provided by financing activities | $19,168 | $73,626 | [Quantitative and Qualitative Disclosures About Market Risk](index=60&type=section&id=Item%207A.%20Quantitative%20and%20Qualitative%20Disclosures%20About%20Market%20Risk) As a "smaller reporting company," Amprius is not required to provide this information - The company is not required to provide this information as it qualifies as a "smaller reporting company"[357](index=357&type=chunk) [Financial Statements and Supplementary Data](index=61&type=section&id=Item%208.%20Financial%20Statements%20and%20Supplementary%20Data) This section contains the company's audited consolidated financial statements for fiscal years 2023 and 2022 Key Balance Sheet Data (in thousands) | | Dec 31, 2023 | Dec 31, 2022 | | :--- | :--- | :--- | | Cash and cash equivalents | $45,761 | $69,696 | | Total current assets | $50,522 | $75,173 | | Property, plant and equipment, net | $21,760 | $4,236 | | Total assets | $107,736 | $83,171 | | Total current liabilities | $13,457 | $6,917 | | Total liabilities | $47,936 | $10,138 | | Total stockholders' equity | $59,800 | $73,033 | Key Statement of Operations Data (in thousands) | | Year ended Dec 31, 2023 | Year ended Dec 31, 2022 | | :--- | :--- | :--- | | Revenue | $9,053 | $4,409 | | Gross loss | $(14,676) | $(5,654) | | Loss from operations | $(38,709) | $(18,041) | | Net loss | $(36,776) | $(17,332) | | Net loss per share (basic and diluted) | $(0.43) | $(0.24) | [Changes in and Disagreements With Accountants on Accounting and Financial Disclosures](index=91&type=section&id=Item%209.%20Changes%20in%20and%20Disagreements%20With%20Accountants%20on%20Accounting%20and%20Financial%20Disclosures) The company reports no changes in or disagreements with its accountants on accounting and financial disclosures - None[515](index=515&type=chunk) [Controls and Procedures](index=91&type=section&id=Item%209A.%20Controls%20and%20Procedures) Management concluded disclosure controls were ineffective due to unremediated material weaknesses in internal control over financial reporting - Management concluded that disclosure controls and procedures were **not effective** as of December 31, 2023, due to unremediated material weaknesses in internal control over financial reporting[516](index=516&type=chunk) - The material weaknesses pertain to (i) inadequate design and maintenance of internal controls over financial reporting and close activities, and (ii) inadequate segregation of duties, attributed to inadequate controls over new application systems[517](index=517&type=chunk) - A remediation plan is underway to enhance application system controls, improve transaction review processes, and engage external specialists to assist with monitoring and implementing controls[519](index=519&type=chunk) [Other Information](index=92&type=section&id=Item%209B.%20Other%20Information) This section discloses the adoption of Rule 10b5-1 stock trading plans by several company executives during 2023 - Discloses the adoption of Rule 10b5-1 trading plans by CTO Dr. Constantin Ionel Stefan (**Dec 2023**), CEO Dr. Kang Sun (**Sep 2023**), and President of Amprius Lab Jonathan Bornstein (**May 2023**)[524](index=524&type=chunk)[525](index=525&type=chunk) [Disclosure Regarding Foreign Jurisdictions that Prevent Inspections](index=92&type=section&id=Item%209C.%20Disclosure%20Regarding%20Foreign%20Jurisdictions%20that%20Prevent%20Inspections) This item is not applicable to the company - None[525](index=525&type=chunk) Part III [Directors, Executive Officers and Corporate Governance](index=93&type=section&id=Item%2010.%20Directors%2C%20Executive%20Officers%20and%20Corporate%20Governance) Information for this item is incorporated by reference from the 2024 Annual Meeting Proxy Statement - Information is incorporated by reference from the definitive Proxy Statement for the 2024 Annual Meeting of Stockholders[527](index=527&type=chunk) [Executive Compensation](index=93&type=section&id=Item%2011.%20Executive%20Compensation) Information for this item is incorporated by reference from the 2024 Annual Meeting Proxy Statement - Information is incorporated by reference from the definitive Proxy Statement for the 2024 Annual Meeting of Stockholders[528](index=528&type=chunk) [Security Ownership of Certain Beneficial Owner and Management and Related Stockholder Matters](index=93&type=section&id=Item%2012.%20Security%20Ownership%20of%20Certain%20Beneficial%20Owner%20and%20Management%20and%20Related%20Stockholder%20Matters) Information for this item is incorporated by reference from the 2024 Annual Meeting Proxy Statement - Information is incorporated by reference from the definitive Proxy Statement for the 2024 Annual Meeting of Stockholders[529](index=529&type=chunk) [Certain Relationships and Related Transactions, and Director Independence](index=93&type=section&id=Item%2013.%20Certain%20Relationships%20and%20Related%20Transactions%2C%20and%20Director%20Independence) Information for this item is incorporated by reference from the 2024 Annual Meeting Proxy Statement - Information is incorporated by reference from the definitive Proxy Statement for the 2024 Annual Meeting of Stockholders[530](index=530&type=chunk) [Principal Accountant Fees and Services](index=93&type=section&id=Item%2014.%20Principal%20Accountant%20Fees%20and%20Services) Information for this item is incorporated by reference from the 2024 Annual Meeting Proxy Statement - Information is incorporated by reference from the definitive Proxy Statement for the 2024 Annual Meeting of Stockholders[531](index=531&type=chunk) Part IV [Exhibit and Financial Statement Schedules](index=94&type=section&id=Item%2015.%20Exhibit%20and%20Financial%20Statement%20Schedules) This section lists the documents filed as part of the Annual Report on Form 10-K, including financial statements and exhibits - This section provides an index to the consolidated financial statements and a list of all exhibits filed with the Form 10-K[533](index=533&type=chunk)[534](index=534&type=chunk) [Form 10-K Summary](index=96&type=section&id=Item%2016.%20Form%2010-K%20Summary) This item is not applicable to the company - None[538](index=538&type=chunk)

Financial Data and Key Metrics - Q4 2023 revenue was $3.9 million, a $3.1 million increase compared to $0.8 million in Q4 2022, and up $1.1 million sequentially [20] - Full-year 2023 revenue was $9.1 million, representing a growth rate of over 100% from 2022 [21] - Gross margin for 2023 was negative 162%, compared to negative 128% in 2022, with significant variation due to product and services revenue mix fluctuations [22] - Operating expenses for 2023 were $24 million, a 94% increase from the prior year, driven by public company expenses, transaction-related costs, and staffing increases in R&D and sales [22] - GAAP net loss for 2023 was $36.8 million, or $0.43 per share, compared to a net loss of $0.24 per share in 2022 [23] - Cash balance at the end of 2023 was $45.8 million with no debt [24] Business Line Data and Key Metrics - Product revenue increased by $0.3 million in Q4 2023, driven by shipments to 41 customers, a record for the company [20] - Development services revenue increased by $3 million in Q4 2023, reflecting the completion of the U.S. Army Manufacturing Technology Program [21] - SiMaxx and SiCore battery families have attracted significant market attention and customer demand, with SiCore offering form factor flexibility for pouch and cylindrical cells [11][33] - The company shipped batteries to 41 customers in Q4 2023, including 16 new customers, with significant orders from eVTOL and HAPS manufacturers [13][14] Market Data and Key Metrics - The company has a strong patent portfolio with over 80 issued patents and pending applications, positioning it as a leader in silicon anode battery technology [5] - Amprius batteries deliver 450 watt-hour per kilo specific energy density and 1,150 watt-hour per liter volumetric density, with a new 500 watt-hour per kilo platform ready for commercial shipments [5][9] - The company has secured long-term battery supply agreements with key customers, including AeroVironment and Tenergy [13] - The company is targeting large markets, including a $1.25 billion conformal wearable battery market by 2030, a $33 billion aviation battery market by 2030, and a $591 billion EV battery market by 2033 [29] Company Strategy and Industry Competition - The company's strategy focuses on advancing silicon anode battery technology, expanding production capacity, and meeting significant customer demand [8][28] - Amprius is building a large-scale manufacturing facility in Brighton, Colorado, expected to be operational in 2025, and has increased manufacturing capacity in Fremont, California, by 10 times [15][16] - The company is pursuing additional funding through equity issuances, grants, loans, and incentives to support its growth strategy [26] - Amprius has been recognized as one of Fast Company's 2024 most innovative companies and won awards for its SiMaxx 400 watt-hour per kilo cell [18] Management Commentary on Operating Environment and Future Outlook - Management highlighted the unmatched performance of Amprius' silicon anode batteries, with significant customer demand and a robust pipeline [27] - The company expects to begin construction of its gigawatt-scale facility in Brighton, Colorado, in 2024 and optimize SiMaxx mass production in Fremont [28] - Management is confident in the company's growth strategy, with opportunities in aviation, EVs, and wearable markets [29] - The company is pursuing the 45x tax credit under the IRA, which could provide significant financial benefits [42] Other Important Information - The company completed its first volume shipments of Safe Cell for the U.S. Army in December 2023, marking a milestone in its manufacturing scale-up initiative [15] - Amprius received AS9100:2016 certification for its Fremont production facility, supporting its supply to the electrical aviation industry [17] - The company has raised $6.5 million through the sale of shares under its ATM facility as of March 18, 2024 [25] Q&A Session Summary Question: Customer feedback and opportunities for SiCore - SiCore has received strong feedback from customers, with form factor flexibility enabling supply of both pouch and cylindrical cells [32][33] Question: Ramp-up challenges and Colorado facility progress - The Fremont facility is expected to reach 2 megawatt-hour capacity by the end of 2024, while the Colorado facility is progressing with rezoning and permitting [35] Question: Revenue breakdown between SiMaxx and SiCore - The company has not disclosed separate revenue figures for SiMaxx and SiCore, but SiCore has potential for larger revenue due to toll manufacturing capacity [38][40] Question: Pricing and application focus for SiCore - SiCore commands a premium due to its high energy density and long cycle life, with applications in aviation and other electric mobility segments [45][47] Question: Demand and ramp for SiCore - Manufacturing capacity for SiCore exceeds 100 megawatts, with commercial revenue expected later in 2024 as customers complete qualification [50] Question: Fremont facility updates and cathode line - The cathode line in Fremont is expected to be operational in Q3 2024, with no impact on current production [52] Question: 500 watt-hour per kilo product timing and R&D goals - The 500 watt-hour per kilo product is expected to ship to customers in 2024, with R&D focused on energy density, power, and safety features [56][58] Question: Fremont capacity and revenue expectations for 2024 - Revenue is expected to ramp up in 2024, driven by Fremont capacity and SiCore product availability [65] Question: Colorado facility long lead time items and costs - Long lead time items for the Colorado facility, such as dehumidifiers and transformers, have been procured, with design and permitting ongoing [68] Question: Gross margin and operating cost expectations for 2024 - Gross margins may remain under pressure in 2024 due to Colorado facility costs, while operating expenses are expected to remain stable [71] Question: Military vs commercial revenue mix - The company does not directly track military vs commercial revenue, as it sells through OEMs, but has strong relationships with key defense contractors [73]

Exhibit 99.1 le ar LETTER TO SHAREHOLDERS Q4 and Full Year 2023 | --- | --- | --- | --- | --- | |-------|----------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------|-------| | | Letter to Shareholders March 2024 | | | | | | F ...

Core Insights - Amprius Technologies, Inc. (AMPX) is anticipated to perform well in the upcoming earnings report due to favorable earnings estimate revisions [1][2] - Analysts have raised their earnings estimates for AMPX, indicating positive trends, with the Most Accurate Estimate for the current quarter at a loss of 10 cents per share, compared to the broader Zacks Consensus Estimate of a loss of 12 cents per share [1] - The Zacks Earnings ESP for AMPX stands at +13.04%, suggesting a strong potential for an earnings beat [1] Importance of Earnings ESP - A positive Zacks Earnings ESP has historically led to positive surprises and outperformance in the market, with a 10-year backtest showing nearly 70% of stocks with a positive Earnings ESP and a Zacks Rank 3 or better achieving positive surprises [2] - Stocks with a positive Earnings ESP have averaged over 28% in annual returns, making AMPX a stock to consider ahead of earnings due to its Zacks Rank 3 and positive ESP [2] - Recent earnings estimate revisions for AMPX indicate a favorable outlook, suggesting a potential earnings beat in the upcoming report [2]

FREMONT, Calif. & ORLANDO, Fla.--(BUSINESS WIRE)--Amprius Technologies, Inc. ("Amprius" or the “Company”) (NYSE: AMPX), a leader in next-generation lithium-ion batteries with its Silicon Anode Platform, is pleased to announce that its SiMaxxTM 400 Wh/kg cell capable of delivering a 10C continuous discharge rate won the Best of Show New Product Award, as voted on by energy industry professionals attending the 2024 International Battery Seminar. “We are honored to receive the Best of Show New Product Award ...

Core Viewpoint - Amprius Technologies (AMPX) is expected to report a year-over-year decline in earnings despite higher revenues, with the earnings report set for March 21, 2024 [1] Revenue and Earnings Estimates - The company is projected to post a quarterly loss of $0.12 per share, reflecting a year-over-year change of -71.4% [2] - Revenues are anticipated to reach $2.6 million, representing a significant increase of 229.1% from the same quarter last year [2] Estimate Revisions - The consensus EPS estimate has been revised 4.35% higher in the last 30 days, indicating a reassessment by covering analysts [2] - The Most Accurate Estimate for Amprius is higher than the Zacks Consensus Estimate, resulting in an Earnings ESP of +16.67% [5] Earnings Surprise Prediction - A positive Earnings ESP is a strong indicator of an earnings beat, especially when combined with a Zacks Rank of 1, 2, or 3 [4] - Amprius currently holds a Zacks Rank of 3, suggesting a likelihood of beating the consensus EPS estimate [6] Historical Performance - In the last reported quarter, Amprius was expected to post a loss of $0.13 per share but actually reported a loss of $0.10, achieving a surprise of +23.08% [7] - Over the past four quarters, the company has only beaten consensus EPS estimates once [7] Conclusion - Amprius is viewed as a compelling candidate for an earnings beat, but investors should consider other factors influencing stock performance ahead of the earnings release [8]

FREMONT, Calif.--(BUSINESS WIRE)--Amprius Technologies, Inc. (“Amprius” or the “Company”) (NYSE: AMPX), a leader in next-generation lithium-ion batteries with its Silicon Anode Platform, today announced it completed a high-volume shipment of SiMaxx™ cells to the Korean Aerospace Research Institute (“KARI”), known as the aeronautics and space agency of South Korea, further strengthening Amprius’ position as the premier global battery solution for HAPS applications. “This partnership with KARI achieves sev ...

Parkev Tatevosian, CFA has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. Parkev Tatevosian is an affiliate of The Motley Fool and may be compensated for promoting its services. If you choose to subscribe through his link, he will earn some extra money that supports his channel. His opinions remain his own and are unaffected by The Motley Fool. ...

FREMONT, Calif.--(BUSINESS WIRE)--Amprius Technologies, Inc. (“Amprius” or the “Company”) (NYSE: AMPX), a leader in next-generation lithium-ion batteries with its Silicon Anode Platform, today announced its schedule for February appearances and activities. Solid-State Batteries: Innovations, Promising Start-Ups, and Future Roadmap Date: February 14-15, 2024 Location: Virtual Event Details: The Solid-State Batteries: Innovations, Promising Start-Ups, and Future Roadmap brings experts together to share resea ...

FREMONT, Calif.--(BUSINESS WIRE)--Amprius Technologies, Inc. (“Amprius” or the “Company”) (NYSE: AMPX), a leader in next-generation lithium-ion batteries with its Silicon Anode Platform, today announced it has received the prestigious AS9100:2016 certification for its Fremont, CA production facility. This certification, received from Smithers Quality Assessments, Inc., establishes a framework for continual improvement as Amprius continues to supply batteries to the burgeoning electric aviation industry, hel ...